Literature DB >> 11786496

Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats.

Regina Gisbert1, Khalid Ziani, Raquel Miquel, M Antonia Noguera, M Dolores Ivorra, Elsa Anselmi, Pilar D'Ocon.   

Abstract

1. The role of a constitutively active population of alpha(1D)-adrenoceptors was analysed in arteries obtained from spontaneously hypertensive rats (SHR) and controls (WKY) divided into three groups: young prehypertensive, adult hypertensive, and adult animals chronically treated with captopril (50 mg kg(-1) per day orally) in order to prevent the hypertensive state. 2. In adult SHR, a significant increase in BMY 7378 potency (not in prazosin potency) was observed in aorta, mesenteric artery, and the first and second branches of the small mesenteric arteries with respect to WKY rats. This difference was not observed in iliac and tail arteries, which suggests an increased functional role of alpha(1D)-adrenoceptors only in some vessels of SHR. 3. The increase in the resting tone (IRT) observed in absence of agonist, inhibited by BMY 7378, that represents the constitutively active population of alpha(1D)-adrenoceptors, was also significantly greater in aorta and mesenteric artery from adult SHR. 4. In young and captopril treated adult animals, no differences between strains with respect to BMY 7378 potency, or IRT were observed. 5. The increase in the functional role of alpha(1D)-adrenoceptors and their constitutive activity observed in hypertension is prevented by captopril treatment. The pathological consequence of this change is the slower rate of recovery of the basal tone after removal of an adrenergic stimulus, observed in vessels from hypertensive animals that had shown an increase in the functionality of constitutively active alpha(1D)-adrenoceptors. This change was not observed in prehypertensive or captopril treated animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786496      PMCID: PMC1573111          DOI: 10.1038/sj.bjp.0704447

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction.

Authors:  S L Hrometz; S E Edelmann; D F McCune; J R Olges; R W Hadley; D M Perez; M T Piascik
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

2.  Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats.

Authors:  R Villalobos-Molina; J J López-Guerrero; M Ibarra
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 3.  Vascular alpha 1D-adrenoceptors: are they related to hypertension?

Authors:  R Villalobos-Molina; M Ibarra
Journal:  Arch Med Res       Date:  1999 Sep-Oct       Impact factor: 2.235

4.  Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction.

Authors:  M Ibarra; J P Pardo; J J Lopez-Guerrero; R Villalobos-Molina
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Alteration of alpha1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats.

Authors:  K Xu; Z Lu; H Wei; Y Zhang; C Han
Journal:  Eur J Pharmacol       Date:  1998-02-26       Impact factor: 4.432

Review 6.  Mechanisms involved in the increased vascular resistance in hypertension.

Authors:  J Marín
Journal:  J Auton Pharmacol       Date:  1993-04

7.  Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery.

Authors:  W B Stam; P H Van der Graaf; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists.

Authors:  D F McCune; S E Edelmann; J R Olges; G R Post; B A Waldrop; D J Waugh; D M Perez; M T Piascik
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

9.  Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing alpha1d-adrenoceptors.

Authors:  J A García-Sáinz; M E Torres-Padilla
Journal:  FEBS Lett       Date:  1999-01-29       Impact factor: 4.124

10.  Characterization of two different Ca2+ entry pathways dependent on depletion of internal Ca2+ pools in rat aorta.

Authors:  M A Noguera; Y Madrero; M D Ivorra; P D'Ocon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-02       Impact factor: 3.000

View more
  9 in total

1.  Ready, set, flow! But how does the flow know where to go?

Authors:  Gail D Thomas
Journal:  J Physiol       Date:  2010-10-01       Impact factor: 5.182

2.  Signaling properties of human alpha(1D)-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization.

Authors:  C Ekaterina Rodríguez-Pérez; M Teresa Romero-Avila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-21       Impact factor: 3.000

Review 3.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

4.  Vascular alpha-1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: role of increased angiotensin II.

Authors:  R Villalobos-Molina; F G Vázquez-Cuevas; J J López-Guerrero; M C Figueroa-García; I A Gallardo-Ortiz; M Ibarra; M Rodríguez-Sosa; F J Gonzalez; G Elizondo
Journal:  Auton Autacoid Pharmacol       Date:  2008 Apr-Jul

5.  Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.

Authors:  Regina Gisbert; Yolanda Madrero; Valentina Sabino; M Antonia Noguera; M Dolores Ivorra; Pilar D'Ocon
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

6.  The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals.

Authors:  Daryl Shorter; David A Nielsen; Sara C Hamon; Ellen M Nielsen; Thomas R Kosten; Thomas F Newton; Richard De La Garza
Journal:  Pharmacogenet Genomics       Date:  2016-09       Impact factor: 2.089

Review 7.  The α1-adrenergic receptors: diversity of signaling networks and regulation.

Authors:  Susanna Cotecchia
Journal:  J Recept Signal Transduct Res       Date:  2010-10-18       Impact factor: 2.092

8.  α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.

Authors:  Nicla Flacco; Jaime Parés; Eva Serna; Vanessa Segura; Diana Vicente; Miguel Pérez-Aso; María Antonia Noguera; María Dolores Ivorra; John C McGrath; Pilar D'Ocon
Journal:  Pharmacol Res Perspect       Date:  2013-08-28

9.  β-Citronellol, an alcoholic monoterpene with inhibitory properties on the contractility of rat trachea.

Authors:  T B Vasconcelos; H V Ribeiro-Filho; L T Lucetti; P J C Magalhães
Journal:  Braz J Med Biol Res       Date:  2015-12-04       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.